FDA Advisers Back Moderna, Pfizer Covid Shots for Youngest (1)

Covid vaccines for infants and toddlers fromModerna Inc. and Pfizer Inc. won support from a panel of US regulatory advisers, putting parents one step closer to being able to protect their youngest against Covid-19 for the first time.

The 21-member committee advising the Food and Drug Administration voted unanimously in favor of clearance for Pfizer’s three-dose vaccine for youngsters ages six months through 4 years. Earlier Wednesday, it gave the same strong endorsement to Moderna’s two-dose for children six months through 5 years. The FDA doesn’t have to follow the recommendations of its advisory panels, but it usually does. ...